We found antithrombin antibody levels to be elevated above the cutoff in 31.3% of our APS patient cohort, with no significant correlation between antithrombin antibody levels and aCL or anti-β2GPI antibody levels. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.